Incubation period
Incubation period of the virus 4 days (IQR, 2-7).
Epidemiological Characteristics of COVID-19; a Systemic Review and Meta-Analysis 1: 5.84 (99% CI: 4.83, 6.85) days.
Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study mean incubation period of 5.2 days.
Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study 4 (3-7) days.
Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study: 5 days (range 2-9 days).
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries Summary Background: 7.44 days.
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms: 4 days (IQR 3-7 days).

Is a 14-day quarantine period optimal for effectively controlling coronavirus disease 2019 (COVID-19)?
The median incubation period of both male and female adults was similar (7-day) but significantly shorter than that (9-day) of child cases.
The difference in the incubation period of 2019 novel coronavirus (SARS-CoV-2) infection between travelers to Hubei and non-travelers: The need of a longer quarantine period: 1.8 and 7.2 days.
Clinical Characteristics of 34 Children with Coronavirus Disease-2019 in the West of China: a Multiple-center Case Series: 10.50 (7.75 -25.25) days.
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures: 4 days (IQR 3-6).
Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study median of incubation period is 8·13 days (95% confidence interval [CI]: 7·37-8·91), the mean is 8·62 days (95% CI: 8·02-9·28).
Clinical Characteristics of SARS-CoV-2 Pneumonia Compared to Controls in Chinese Han Population 4 days (IQR, 2 to 7).
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application 5.1 days (CI, 4.5 to 5.8 days).
Transmission of corona virus disease 2019 during the incubation period may lead to a quarantine loophole: 4.9 days (95% confidence interval [CI], 4.4 to 5.4) days.
Transmission interval estimates suggest pre-symptomatic spread of COVID-19: 7.1 (6.13, 8.25) days for Singapore and 9 (7.92, 10.2) days for Tianjin.
Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China: 6 days, ranged from 1 to 32 days.
Characteristics of COVID-19 infection in Beijing: 6.7 days.
Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series: 6 (IQR, 3-8) days.
A descriptive study of the impact of diseases control and prevention on the epidemics 1 dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for 6.4 days (95% 175 CI 5.3 to 7.6).
Epidemiological characteristics of 1212 COVID-19 patients in Henan, China. medRxiv average, mode and median incubation periods are 7.4, 4 and 7 days.
Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data: 5.6 days (95% CI: 4.4, 7.4).
The incubation period of 2019-nCoV infections among travellers from Wuhan, China: 6.4 (5.6 -7.7, 95% CI) days.
Viral Kinetics and Antibody Responses in Patients with COVID-19 2 days (range, 3-38 ) in nasopharyngeal swabs, 19 days (range, 5-37) in sputum and 18 days (range, 7-26) in stools.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study 20·0 days (IQR 17·0-24·0).
Children are unlikely to have been the primary source of household SARS-CoV-2 infections:7.74 d ± 3.22.

Is a 14-day quarantine period optimal for effectively controlling coronavirus disease 2019 (COVID-19)?
median incubation period of both male and female adults was similar (7-day) but significantly shorter than that (9-day) of child cases.
Clinical Characteristics of 34 Children with Coronavirus Disease-2019 in the West of China: a Multiple-center Case Series: 10.50 (7.75 -25.25) days.
Asymptomatic shedding. What is the proportion of patients who were asymptomatic? 21.70%.
High incidence of asymptomatic SARS-CoV-2 infection, Chongqing, China 19%.
High transmissibility of COVID-19 near symptom onset there were 32 laboratory-confirmed COVID-19 patients, including five household/family clusters and four asymptomatic patients.
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries 49 (14.89%) were asymptomatic.
Estimating the Asymptomatic Proportion of 2019 Novel Coronavirus onboard the Princess Cruises Ship, 2020 17.90%.
Clinical Characteristics of 24 Asymptomatic Infections with COVID-19 Screened among Close Contacts in Nanjing, China. The remaining 7 (29.2%) cases showed normal CT image and had no symptoms during hospitalization.
Characteristics of COVID-19 infection in Beijing 13 (5.0%) asymptomatic cases.
Persistence of sources. What is the length of viral shedding in stool?
Length of viral shedding in stool detected in feces till 14 days after the onset of symptoms.

Diagnostics
Viral Kinetics and Antibody Responses in Patients with COVID-19 18 days (range, 7-26).
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients 2 3 22.0 days (IQR 15.5 to 23.5).
What is the sensitivity and specificity of COVID-19 tests? The overall sensitivity, specificity and diagnostic accuracy of RT-dPCR were 90%, 100% and 93 %, respectively.
Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing. The areas under the ROC curves of IgM and IgG were 0.988 and 1.000, respectively.
Clinical significance of IgM and IgG test for diagnosis of highly suspected COVID-19 infection. The positive detection rate of combination of IgM and IgG for patients with COVID-19 negative and positive nucleic acid test was 72.73% and 87.50%.
Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area the overall accuracy rate of CT examination in the present study was 97.3%.
Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP colorimetric LAMP assay showed 100% agreement with the RT-qPCR results across a range of C q values.
Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? Sensitivity was therefore 97.2%.
Rapid colorimetric detection of COVID-19 coronavirus using a reverse tran- scriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic plat- form: iLACO. iLACO is very sensitive, and as low as 10 copies of ORF1ab gene were detected successfully.
What is the sensitivity and specificity of COVID-19 tests? A large series based on 1014 patients reported a 97% sensitivity of chest CT for the diagnosis of COVID-19, while the mean time interval between initial negative and positive RT-PCR was approximately 5 days.

Seasonality
How does temperature affect the transmission of COVID-19? Adjusted incidence rate ratios suggested brighter, warmer and drier conditions were associated with lower incidence.
Climate effect on COVID-19 spread rate: an online surveillance tool a plausible negative correlation between warmer climate and COVID-19 spread rate.
How does temperature affect the transmission of COVID-19? Causal empirical estimates suggest COVID-19 transmission rates are highly seasonal.
How does temperature affect the transmission of COVID-19? Increase in local temperature reduces new COVID-19 cases per 1 million people by 13%, with a 95% confidence interval of [-21%, -4%].
How does temperature affect the transmission of COVID-19? Climate affects global patterns of COVID-19 early outbreak dynamics.
How does temperature affect the transmission of COVID-19? Temperature and humidity strongly impact the variation of the growth rate of Covid-19 cases across the globe.
How does temperature affect the transmission of COVID-20? Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19, for cases reported globally up to 29th February 2020.
How does temperature affect the transmission of COVID-21? Higher average temperature was strongly associated with lower COVID-19 incidence for temperatures of 1°C and higher.

Physical science
What purity of ethanol inactivates COVID-19? Purity of ethanol to inactivate COVID-19.
What purity of ethanol inactivates COVID-20? WHO 21 formulation I, based on 85 % ethanol, efficiently inactivated the virus with reduction 22 factors.
What purity of ethanol inactivates COVID-21? Both alcohols, ethanol (Fig. 9 2A) and 2-propanol ( Fig. 2B) were able to reduce viral titers in 30 s exposure minimal concentration of 30 % ethanol or 2-propanol is sufficient for viral 12 inactivation.
What purity of ethanol inactivates COVID-22? Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols.

Metaresearch
How large is the sample size used in COVID-19 studies? Sample size used in COVID-19 studies 49 cases.
Longitudinal analysis of laboratory findings during the process of recovery for patients with COVID-19 59 cases.
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries Summary Background 587 cases.
Is a 14-day quarantine period optimal for effectively controlling coronavirus disease 2019 (COVID-19)? 2015 cases.
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures 36 individuals.
Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study sample size of 1211.
Epidemiologic Characteristics of COVID-19 in Guizhou, China Affiliations: Guizhou Center for Disease Control and Prevention Abstract 162 cases.
Clinical Characteristics of SARS-CoV-2 Pneumonia Compared to Controls in Chinese Han Population 69 hospitalized patients.
Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China 104 cases.
Epidemiological characteristics of 1212 COVID-19 patients in Henan, China. medRxiv 1212 patients.
The incubation period of 2019-nCoV infections among travellers from Wuhan, China 88 confirmed cases.
Viral Kinetics and Antibody Responses in Patients with COVID-19 67 patients.
Children are unlikely to have been the primary source of household SARS-CoV-2 infections 40 articles.
A considerable proportion of individuals with asymptomatic SARS- CoV-2 infection in Tibetan population 83 cases.
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries Summary Background 329 cases.
Estimating the Asymptomatic Proportion of 2019 Novel Coronavirus onboard the Princess Cruises Ship, 2020 634 cases.

Hypertension
What is the RR for severe infection in COVID-19 patients with hypertension? RR for severe infection in COVID-19 patients with hypertension.
The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis	hypertension (10 studies; 2.74 [2.12-3.54]).
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis Running title: Predictors of clinical prognosis of COVID-19 hypertension (RR = 4.48; 95% CI).

Diabetes
What is the OR for severe infection in COVID-19 patients with diabetes? OR for severe infection in COVID-19 patients with diabetes.
Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis OR = 3.04 [2.01, 4.60].
Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis [OR=2.67, 95% CI (1.91, 3.74), P<0.01].
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis Running title: Predictors of clinical prognosis of COVID-19 2.49; 95% CI, ; n = 10; I 2 = 44%.
Journal Pre-proof Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis Prevalence of comorbidities in the Novel Wuhan Coronavirus (COVID-19) infection: a systematic review and meta-analysis OR 2.07, 95% CI: 0.89-4.82.
Journal Pre-proof Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis Prevalence of comorbidities in the Novel Wuhan Coronavirus (COVID-19) infection: a systematic review and meta-analysis OR 2.07, 95% CI: 0.89-4.82.

